If you're like even the most enthusiastic of small cap aficionados, you've probably never heard of Viropro. That's ok. Though VPRO has been trading for years, it's only been effectively trading (on any meaningful volume) since the beginning of this year. That's when the company, aka Alpha Biologics after a name change last month, inked a deal with Spectrum Pharmaceuticals to do for the what it 'does'...which is offer technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases. Now, if you know what that means simply from reading it one time, get a life. For the rest of us, it means that Viropro Inc. helps other biopharma companies make drugs to use in their own pre-clinical, Phase1, and clinical trials.
Anyway, though it's been erratic to be sure, VPRO has also been taking two steps forward and one step back on a pretty reliable basis since January. The result is the development of a rising support line (purple), and a near-term horizontal ceiling at $0.06. If that level, and then the $0.086 mark can be knocked over, Viropro could take off. I'd rather be in this small cap stock before then though
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.